Here, we report the unusual case of a 47-yr-old female smoker with stage IV LCNEC featuring EML4–ALK variant 2 (E20:A20), wild-type TP53/RB1, and low tumor mutational burden of 3.91 mut/Mb. This evidence concerns the gene ALK and large cell neuroendocrine carcinoma.